Episode 1 ─ Should We Be Rethinking the Scientific Publication?

Is the scientific publication, as we know it, dead?

This was the central question behind the theme for this year’s DDEA Postdoc Summit Challenge.

Researchers learn early on to think in terms of impact factors and citation metrics. In an overflowing ocean of scientific content, the pressure to make your publications matter seems higher than ever. Yet according to recent studies, the impact of Danish research has been on an overall steady decline, and papers are generally becoming less disruptive over time.

But what is scientific impact and how is it measured? And is it time to look at alternatives to a practice that has changed very little in the last 100 years?

In this episode, we hand over the microphone to a postdoc, Christopher Lewis, who landed an interview with none other than the Senior Vice President of Impact at the Novo Nordisk Foundation, Thomas Alslev Christensen.

Listen, as an early-career researcher addresses the burning questions about the direction of scientific impact to one with a job specifically tied to this subject at a highly influential research institution.

The Novo Nordisk Foundation

The Novo Nordisk Foundation (NNF) is a Danish foundation supporting the business and research activities of the Novo Group’s companies (Novo Nordisk A/S and Novozymes A/S), providing support for scientific, humanitarian, and social purposes. In 2022, the NNF granted DKK 7.464 billion DKK for a total of 695 new initiatives. The DDEA is funded by the NNF with a five-year grant of 194 million DKK.

Episode info


  • Thomas Alslev Christensen, Senior Vice President of Impact at the Novo Nordisk Foundation


  • Christopher Lewis, Postdoc, University of Copenhagen


Danish Diabetes and Endocrine Academy


Nikolai Rosler – Rosler Productions 


Gretchen Repasky, Education & Networking Manager, DDEA

Copyright © 2023 Danish Diabetes and Endocrine Academy. All Rights Reserved • Privacy Policy